Who Participates in Clinical Research?
People of all ages participate in clinical research through the Conquering Diseases program. Participants may be healthy volunteers, or they may have serious medical conditions. People of all races, ethnicities, and backgrounds participate in clinical research at UMass Memorial Health Care.
Researchers are starting to understand that some drugs work differently in people of different ages, genders, or ethnicities. It is important that women and people of varied ages and race/ethnicities participate in order to develop drugs and treatments that work well for everyone.
If you or someone you know is interested in participating in research at UMass Memorial, you can start here by searching the study listings on this link or sign up to volunteer for research.
The Importance of Diversity in Research
Researchers and doctors know that some medicines may work differently among men, women, and children, and various racial and ethnic groups. It is very important that all groups be represented in research so that future generations from all backgrounds could benefit.
To learn more about this topic, please visit:
Participant Safety and Protection
Safety is the top priority in all UMass Memorial clinical studies. In fact, before any research study can begin at the University of Massachusetts, it must be approved by the Institutional Review Board (IRB) which is a team of doctors, research and ethical experts and community members. In order to protect the health and safety of our participants, not every person will be eligible for every study.
There have been many changes over the years to protect people who participate in research studies. Stringent Federal laws are in place to protect participants' rights. If you decide to volunteer in a study, you have the right to leave a study at any time, for any reason and cannot be forced to do something you do not want to do.
The University of Massachusetts IRB (Institutional Review Board) is the group that reviews all UMass Memorial research studies involving human subjects. Studies cannot begin without IRB approval.